Allarity Therapeutics, Inc.
ALLR
$1.16
$0.08738.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -332.81% | -160.63% | 31.55% | -14.65% | 39.32% |
| Total Depreciation and Amortization | -88.89% | -44.44% | -88.89% | -80.00% | 350.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.89% | 959.00% | -61.82% | -24.19% | -535.30% |
| Change in Net Operating Assets | 12.31% | -73.79% | -419.48% | 405.78% | 273.58% |
| Cash from Operations | -91.75% | -1.25% | -189.10% | 53.55% | 31.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | 100.00% | 100.00% | 59.98% | -- | -- |
| Issuance of Common Stock | 709.75% | -53.98% | 305.71% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 30.00% | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 711.30% | -24.53% | 818.29% | 19.17% | -47.80% |
| Foreign Exchange rate Adjustments | 508.43% | -105.26% | 29.51% | -18.12% | 81.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 186.78% | -178.65% | 15,036.80% | 108.42% | 35.68% |